Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianpi Sanjie Recipe is a traditional Chinese medicine (TCM) herbal formula used primarily in the prevention and treatment of drug resistance in colorectal cancer. It is administered as part of integrative therapy, often alongside chemotherapy, for patients with stage III and IV colorectal cancer who meet the diagnostic criteria for spleen deficiency syndrome. The precise composition of herbs in this recipe is not specified in the available sources, but it follows TCM principles aimed at strengthening the spleen ("Jianpi") and resolving accumulations or masses ("Sanjie"). The mechanism of action is not fully elucidated; however, similar TCM formulas have been shown to modulate immune responses, inhibit tumor proliferation and metastasis, induce apoptosis via mitochondrial pathways or death receptor pathways, regulate signaling pathways such as PI3K/Akt/mTOR or NF-κB, and potentially reduce multidrug resistance markers like MDR1 mRNA[1][2]. Clinical studies are ongoing to evaluate its efficacy specifically against drug resistance in colorectal cancer[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jianpi Sanjie Recipe.